Transforming childhood cancer treatment: key insights

Navigating breast cancer treatment for young patients

Optimizing oncology: The future of treatment studies

Exploring soft tissue sarcomas and health economics in oncology

Advancements in head and neck cancer treatment in India

Multiple Myeloma: evolving paradigm - Panel Discussion

New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy-induced nausea and vomiting in NSCLC patients

Empowering cancer survivorship: collaboration and care

Empowering women in oncology: insights and networking

Advancements in paediatric Acute lymphoblastic leukemia management

Enhancing head and neck oncology: Key insights from the conference

Tusamitamab ravtansine versus docetaxel in previously treated advanced nonsquamous NSCLC: Results from phase 3 CARMEN-LC03 trial